Christine (Chris) Marsh, Senior Vice President, currently leads the Value & Access Organization for Boehringer Ingelheim Pharmaceuticals, Inc. She collaborates daily with cross functional leaders and dedicated teams to ensure that no patient is denied access to our medicines that transform lives.

Chris was named as the newest SAMA (Strategic Account Management Association) board member, in March 2025, in addition to being a current board member and past Chair of the National Pharmaceutical Council (NPC) and a member to the Connecticut Drug Pricing Steering Committee. While a dedicated member of her organization, she also leverages these platforms to advocate for improved access to treatments for the patients we serve. Chris’ expertise and commitment have made her a highly respected voice in the industry, and her contributions have helped to shape the industry in a more patient-centric direction.  

Chris is a proud mother of two daughters and a graduate of Kent State University, with an M.B.A. in Finance from Xavier University.